A recent study found that people who received Zostavax, a older shingles vaccine, had a lower risk of developing dementia.

Researchers tracked more than 280,000 adults in Wales and found that the shingles vaccine cut the risk of developing dementia by 20% over a seven-year period. The new findings, published in Nature, ...

A vaccine to fight dementia? It turns out there may already be one – shots that prevent painful shingles also appear to ...

Women at risk for Alzheimer’s and other causes of dementia may especially benefit from the vaccine, a new study finds.

Taking advantage of a unique public health policy in the UK, a new study has found that receiving the shingles vaccine ...

The strongest set of evidence to date indicates that people who had a shingles vaccine had significantly lower odds of ...

The findings suggest that the shingles virus might play a role in causing at least a subset of dementia cases, Geldsetzer ...

G etting vaccinated for the viral illness shingles, which causes a painful rash, could potentially be the next best tool in ...

If you don't have Medicare prescription drug coverage or you don't yet qualify for Medicare, the full price for two doses of the Shingrix vaccine is $367. The shingles vaccine is free for nearly ...

GSK’s restructuring of its distribution deal for its shingles vaccine Shingrix in December 2024, and MSD’s decision to pause sales of its blockbuster human papillomavirus (HPV) vaccine ...

GSK’s restructuring of its distribution deal for its shingles vaccine Shingrix in December 2024, and MSD’s decision to pause sales of its blockbuster human papillomavirus (HPV) vaccine Gardasil until ...

Today, a brief rundown of news involving Bayer and Axsome Therapeutics, as well as updates from GSK, Novo Nordisk and Augustine Therapeutics that you may have missed. Belgian biotechnology startup ...